Identifying the frequencies of drug-side effects is crucial for assessing drug risk-benefit. However, accurately determining these frequencies remains challenging due to the limitations of time and scale in clinical randomized controlled trials. As a result, several computational methods have been proposed to address these issues. Nonetheless, two primary problems still persist. Firstly, most of these methods face challenges in generating accurate predictions for novel drugs, as they heavily depend on the interaction graph between drugs and side effects (SEs) within their modeling framework. Secondly, some previous methods often simply concatenate the features of drugs and SEs, which fails to effectively capture their underlying association. In this work, we present HSTrans, a novel approach that treats drugs and SEs as sets of substructures, leveraging a transformer encoder for unified substructure embedding and incorporating an interaction module for association capture. Specifically, HSTrans extracts drug substructures through a specialized algorithm and identifies effective substructures for each SE by employing an indicator that measures the importance of each substructure and SE. Additionally, HSTrans applies convolutional neural network (CNN) in the interaction module to capture complex relationships between drugs and SEs. Experimental results on datasets from Galeano et al.'s study demonstrate that the proposed method outperforms other state-of-the-art approaches. The demo codes for HSTrans are available at https://github.com/Dtdtxuky/HSTrans/tree/master.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neunet.2024.106779DOI Listing

Publication Analysis

Top Keywords

drugs ses
12
frequencies drug-side
8
drug-side effects
8
interaction module
8
hstrans
5
drugs
5
hstrans homogeneous
4
substructures
4
homogeneous substructures
4
substructures transformer
4

Similar Publications

Introduction Mental health conditions, such as depression, anxiety, and psychological distress in the adult population significantly increased during the COVID-19 pandemic. However, the rates of prescribing psychotropic medications in adults during the COVID-19 period have not been well explored. Aim The aim of this study was to examine the association between demographic characteristics and rates of prescribing psychotropic medications to general practice patients during 2018-2022.

View Article and Find Full Text PDF

Background: The World Health Organisation (WHO) estimates that about 3.2 billion people which is nearly half of the world's population are at risk of malaria. Annually about 216 million cases and 445,000 deaths of malaria occur globally.

View Article and Find Full Text PDF

More pubs-More problems? A longitudinal analysis of Swedish panel data.

Drug Alcohol Rev

December 2024

Swedish Council for Information on Alcohol and Other Drugs, Stockholm, Sweden.

Introduction: The aim of the study is to estimate the association between bar density and nighttime emergency calls to the police.

Methods: We used a pooled cross-sectional time-series data set covering the Swedish 290 municipalities spanning the time period 2012-2021. As outcome we used nighttime emergency calls to the police and daytime emergency calls to the police as control variable.

View Article and Find Full Text PDF

Aerosol mitigation in upper airway surgery.

Int J Pediatr Otorhinolaryngol

November 2024

Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine, Aurora, CO, USA; Children's Hospital Colorado, Aurora, CO, USA.

Background: Aerosol generating procedures pose a risk for SARS-CoV-2 transmission, and comprise a large percentage of cases performed in otolaryngology. An optimal method to mitigate this hazard does not currently exist. This study examined methods to mitigate surgical aerosols from the operating room.

View Article and Find Full Text PDF

Identifying the frequencies of drug-side effects is crucial for assessing drug risk-benefit. However, accurately determining these frequencies remains challenging due to the limitations of time and scale in clinical randomized controlled trials. As a result, several computational methods have been proposed to address these issues.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!